IBS CAPITAL LLC - 17 Dec 2021 Form 4 Insider Report for Applied Minerals, Inc.

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
4
Accepted by SEC
21 Dec 2021, 16:33:47 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ David A. Taft, President of IBS Capital LLC

Key filing fact

IBS CAPITAL LLC filed Form 4 for Applied Minerals, Inc. on 21 Dec 2021.

Key facts

  • This page summarizes IBS CAPITAL LLC's Form 4 filing for Applied Minerals, Inc..
  • 5 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 21 Dec 2021, 16:33.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: -$25,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AMNL transaction

Common Stock

Sale

Transaction value
$7,015
Shares
-1,403,000
Change %
-6.9%
Price
$0.005000
Shares after
19,033,734
Date
17 Dec 2021
Ownership
See footnotes
Footnotes
F1, F2, F5
AMNL transaction

Common Stock

Sale

Transaction value
$17,985
Shares
-3,597,000
Change %
-16%
Price
$0.005000
Shares after
19,033,734
Date
17 Dec 2021
Ownership
See footnotes
Footnotes
F1, F2, F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AMNL transaction Derivative

10% PIK-Election Convertible Note

Sale

Transaction value
Shares
-1
Change %
-0%
Price
Shares after
1,058,778
Date
17 Dec 2021
Ownership
See footnotes
Underlying class
Common Stock
Underlying amount
Exercise price
$0.3400
Footnotes
F1, F3, F4, F5, F6
AMNL transaction Derivative

10% PIK-Election Convertible Note

Sale

Transaction value
Shares
-1
Change %
-0%
Price
Shares after
1,058,778
Date
17 Dec 2021
Ownership
See footnotes
Underlying class
Common Stock
Underlying amount
Exercise price
$0.3400
Footnotes
F1, F3, F4, F5, F6
AMNL transaction Derivative

10% PIK-Election Convertible Note

Sale

Transaction value
Shares
-1
Change %
-0%
Price
Shares after
1,058,778
Date
17 Dec 2021
Ownership
See footnotes
Underlying class
Common Stock
Underlying amount
Exercise price
$0.3400
Footnotes
F1, F3, F4, F5, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

This Form 4 is being filed on behalf of IBS Capital LLC ("IBS Capital"), The IBS Turnaround Fund (QP), LP (the "QP Fund"), and David A. Taft ("Taft") (IBS Capital, the QP Fund and Taft are each a "Reporting Person"), each of which has the same business address and may have a pecuniary interest in the securities reported herein. IBS Capital is the general partner of QP Fund and The IBS Turnaround Fund, LP (the "LP Fund"). IBS Capital is the investment manager of The IBS Opportunity Fund, Ltd. (the "Opp. Fund" together with the QP Fund and the LP Fund, the "IBS Capital Funds"). Taft is the president and a member of IBS Capital. Taft is no longer a director of the Issuer. As of the date of this filing, none of the LP Fund, the Opp. Fund, QP Fund, IBS Capital or David A. Taft will beneficially own in the aggregate at least 10% of the Issuer (based on the Issuer's 10-Q for the quarterly period ended 9/30/2021, which reports 204,736,762 outstanding common stock shares).

Footnote F2

This transaction is being reported as a result of private transactions in which the LP Fund and the QP Fund sold securities to a third-party purchaser (the "Purchaser"). The LP Fund sold 1,403,000 shares of common stock to the Purchaser and the QP Fund sold 3,597,000 shares of common stock to the Purchaser. These transactions were effected at the same time. As a result of these transactions the overall beneficial ownership of IBS Capital and David Taft decreased to 19,033,734 shares of common stock. Following the transactions 5,902,997 shares of common stock are owned by the LP Fund and 11,655,583 shares of common stock are owned by the QP Fund.

Footnote F3

The LP Fund sold $1,427,792 of principal under a 10% PIK-Election Convertible Note to the Purchaser for $57,111.68, which principal amount is convertible into 4,199,388 shares of common stock of the Issuer. The QP Fund sold $2,867,160 of principal under a 10% PIK-Election Convertible Note to the Purchaser for $114,686.40, which principal amount is convertible into 8,432,824 shares of common stock of the Issuer. The Opp. Fund sold $278,582 of principal under a 10% PIK-Election Convertible to the Purchaser for $11,143.28, which principal amount is convertible into 819,359 shares of common stock of the Issuer.

Footnote F4

As a result of the transactions described in FN 3 IBS Capital and Taft beneficially own derivative securities that are convertible into 1,058,778 shares of common stock of the Issuer. The LP Fund beneficially owns derivative securities that are convertible into 329,317 shares of common stock of the Issuer. The QP Fund beneficially owns derivative securities that are convertible into 665,060 shares of common stock of the Issuer. The Opp. Fund beneficially owns derivative securities that are convertible into 64,401 shares of common stock of the Issuer.

Footnote F5

The Reporting Persons each disclaim any beneficial ownership of the securities except to the extent of any pecuniary interest.

Footnote F6

At the noteholder's option, the amount outstanding under the notes described in Footnote 3 may be converted into common stock of the Issuer. The notes described in Footnote 3 mature on 5/1/2023.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .